Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ ...
Additionally, Pulse Biosciences has reported promising preliminary results from a feasibility study on its Nanosecond Pulsed Field Ablation (nano-PFA) technology, showing potential in reducing ...